Post job

Kura Oncology's revenue is $53.9 million.

What is Kura Oncology's revenue?

Kura Oncology's annual revenue is $53.9M. Zippia's data science team found the following key financial metrics about Kura Oncology after extensive research and analysis.
  • Kura Oncology has 121 employees, and the revenue per employee ratio is $445,314.
  • Kura Oncology peak revenue was $53.9M in 2024.

On this page

Peak revenue
$53.9M (2024)
Company peak revenue
Revenue / employee
$445,314
Company revenue / employee

Zippia finds jobs where you're a top candidate and applies on your behalf.

Floating question marks illustration
Peak revenue
$53.9M (2024)
Company peak revenue
Revenue / employee
$445,314
Company revenue / employee

Kura Oncology financial information

CEOTroy E. Wilson Ph.d
Company TypePublic
Employees Number121
Date Founded2014
HeadquartersSan Diego, California
Number of Locations2
Revenue$53.9M
Net Income-$135,840,000
Tax Rate-0.0%
Total Assets$456,306,000
TickerKURA

Kura Oncology jobs you might like

Kura Oncology financing

Kura Oncology received early financing of $60.0M on 2015-03-12.

SeriesRound sizeDate
Private Equity$60M03/2015
Post Ipo Equity$50M08/2017
Post Ipo Equity$77M06/2018
Post Ipo Equity$115.3M06/2019
Post Ipo Equity$143.9M05/2020
Post Ipo Equity$345M12/2020

Kura Oncology investors

InvestorsSecurity type
Partner Fund ManagementPrivate Equity
EcoR1 Capital LLCPrivate Equity
Osage University PartnersPrivate Equity
Tavistock GroupPrivate Equity
ARCH Venture PartnersPrivate Equity
Nextech InvestPrivate Equity
FMR Co.Private Equity

Kura Oncology revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Kura Oncology, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Kura Oncology. The employee data is based on information from people who have self-reported their past or current employments at Kura Oncology. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Kura Oncology. The data presented on this page does not represent the view of Kura Oncology and its employees or that of Zippia.

Kura Oncology may also be known as or be related to KURA ONCOLOGY INC., Kura Oncology, Kura Oncology Inc and Kura Oncology, Inc.